The Jeonnam Bio Center and the Vaccine Safety Technology Support Center are expanding their collaboration to enhance workforce training in biopharmaceuticals and provide technical support for vaccine development.
According to the Jeonnam Bio Center, the two organizations signed a memorandum of understanding (MOU) on August 24 to foster the continuous growth of the biopharmaceutical industry and meet the demand for specialized personnel in the field.
Under the agreement, the organizations will connect their expertise and research and education infrastructure to identify joint projects in the biopharmaceutical sector and jointly develop and operate training programs aimed at cultivating practical talent.
They will also collaborate in the area of cell banking, which is essential for vaccine development. The two centers plan to share their specialized capabilities in cell banking manufacturing, testing, and storage, and strengthen the technical support system needed during the vaccine and biopharmaceutical development processes.
Notably, the training for specialized personnel will focus on enhancing practical skills that can be applied in the industry, rather than just theoretical knowledge. The curriculum will be designed in response to industry needs, addressing the workforce supply and demand in the biopharmaceutical sector.
Previously, the two organizations have jointly provided specialized practical training in biopharmaceutical production, quality control, and vaccine quality testing for local youth preparing for employment in the biopharmaceutical sector. With this MOU, they plan to expand their existing educational collaboration into joint projects and technical support.
Seo Dong-sam, head of the Jeonnam Bio Center, stated, “We have established a foundation for expanding the training of field-oriented professionals and discovering joint projects by linking the expertise and infrastructure of both organizations. We will enhance our collaborative efforts to cultivate practical talent needed in the vaccine and biopharmaceutical industries and contribute to industrial development.”
Oh Il-woong, head of the Vaccine Safety Technology Support Center, remarked, “The collaboration in workforce training and vaccine development is a crucial foundation for enhancing the competitiveness of the biopharmaceutical industry. We will strengthen cooperation in education and technology to contribute to industrial advancement.”
Meanwhile, the Jeonnam Bio Center is the leading organization for the K-Bio Health Regional Center support project in the Jeonnam and Gwangju areas, promoting the development of biopharmaceutical companies and workforce training by linking the infrastructure of the Hwaseong Vaccine Industry Special Zone and the National Advanced Strategic Industry Bio Specialized Zone.
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.